221 related articles for article (PubMed ID: 34203149)
1. Screening and Identification of Lujo Virus Inhibitors Using a Recombinant Reporter Virus Platform.
Welch SR; Spengler JR; Genzer SC; Chatterjee P; Flint M; Bergeron É; Montgomery JM; Nichol ST; Albariño CG; Spiropoulou CF
Viruses; 2021 Jun; 13(7):. PubMed ID: 34203149
[TBL] [Abstract][Full Text] [Related]
2. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of cannabinoid receptor 1 suppress the cellular entry of Lujo virus.
Kimura M; Matsuoka R; Taniguchi S; Maruyama J; Paessler S; Oka S; Yamashita A; Fukuhara T; Matsuura Y; Tani H
Virology; 2023 Oct; 587():109867. PubMed ID: 37633192
[TBL] [Abstract][Full Text] [Related]
4. Delayed inflammatory and cell death responses are associated with reduced pathogenicity in Lujo virus-infected cynomolgus macaques.
Rasmussen AL; Tchitchek N; Safronetz D; Carter VS; Williams CM; Haddock E; Korth MJ; Feldmann H; Katze MG
J Virol; 2015 Mar; 89(5):2543-52. PubMed ID: 25520505
[TBL] [Abstract][Full Text] [Related]
5. NRP2 and CD63 Are Host Factors for Lujo Virus Cell Entry.
Raaben M; Jae LT; Herbert AS; Kuehne AI; Stubbs SH; Chou YY; Blomen VA; Kirchhausen T; Dye JM; Brummelkamp TR; Whelan SP
Cell Host Microbe; 2017 Nov; 22(5):688-696.e5. PubMed ID: 29120745
[TBL] [Abstract][Full Text] [Related]
6. Molecular Mechanisms Underlying the Cellular Entry and Host Range Restriction of Lujo Virus.
Saito T; Hattori T; Okuya K; Manzoor R; Miyamoto H; Kajihara M; Takada A
mBio; 2021 Feb; 13(1):e0306021. PubMed ID: 35164564
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Lujo virus cell entry using pseudotype vesicular stomatitis virus.
Tani H; Iha K; Shimojima M; Fukushi S; Taniguchi S; Yoshikawa T; Kawaoka Y; Nakasone N; Ninomiya H; Saijo M; Morikawa S
J Virol; 2014 Jul; 88(13):7317-30. PubMed ID: 24741091
[TBL] [Abstract][Full Text] [Related]
8. Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors.
Neuman BW; Bederka LH; Stein DA; Ting JP; Moulton HM; Buchmeier MJ
Antimicrob Agents Chemother; 2011 Oct; 55(10):4631-8. PubMed ID: 21825302
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and patient management of Lujo hemorrhagic fever.
Sewlall NH; Richards G; Duse A; Swanepoel R; Paweska J; Blumberg L; Dinh TH; Bausch D
PLoS Negl Trop Dis; 2014; 8(11):e3233. PubMed ID: 25393244
[TBL] [Abstract][Full Text] [Related]
10. [Lujo hemorrhagic fever].
Sizikova TE; Lebedev VN; Syromyatnikova SI; Borisevich SV
Vopr Virusol; 2017; 62(4):149-153. PubMed ID: 29733163
[TBL] [Abstract][Full Text] [Related]
11. Potent inhibition of arenavirus infection by a novel fusion inhibitor.
Gowen BB; Naik S; Westover JB; Brown ER; Gantla VR; Fetsko A; Dagley AL; Blotter DJ; Anderson N; McCormack K; Henkel G
Antiviral Res; 2021 Sep; 193():105125. PubMed ID: 34197863
[TBL] [Abstract][Full Text] [Related]
12. Novel Arenavirus Entry Inhibitors Discovered by Using a Minigenome Rescue System for High-Throughput Drug Screening.
Rathbun JY; Droniou ME; Damoiseaux R; Haworth KG; Henley JE; Exline CM; Choe H; Cannon PM
J Virol; 2015 Aug; 89(16):8428-43. PubMed ID: 26041296
[TBL] [Abstract][Full Text] [Related]
13. Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses.
Lee AM; Rojek JM; Spiropoulou CF; Gundersen AT; Jin W; Shaginian A; York J; Nunberg JH; Boger DL; Oldstone MB; Kunz S
J Biol Chem; 2008 Jul; 283(27):18734-42. PubMed ID: 18474596
[TBL] [Abstract][Full Text] [Related]
14. [Arenavirus research and antiviral candidate].
Tani H; Shuzo U
Uirusu; 2018; 68(1):51-62. PubMed ID: 31105135
[TBL] [Abstract][Full Text] [Related]
15. Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa.
Briese T; Paweska JT; McMullan LK; Hutchison SK; Street C; Palacios G; Khristova ML; Weyer J; Swanepoel R; Egholm M; Nichol ST; Lipkin WI
PLoS Pathog; 2009 May; 5(5):e1000455. PubMed ID: 19478873
[TBL] [Abstract][Full Text] [Related]
16. Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity.
Miranda PO; Cubitt B; Jacob NT; Janda KD; de la Torre JC
ACS Infect Dis; 2018 May; 4(5):815-824. PubMed ID: 29405696
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs.
Herring S; Oda JM; Wagoner J; Kirchmeier D; O'Connor A; Nelson EA; Huang Q; Liang Y; DeWald LE; Johansen LM; Glass PJ; Olinger GG; Ianevski A; Aittokallio T; Paine MF; Fink SL; White JM; Polyak SJ
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468464
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor.
Ortiz-Riaño E; Ngo N; Devito S; Eggink D; Munger J; Shaw ML; de la Torre JC; Martínez-Sobrido L
J Virol; 2014 Jan; 88(2):878-89. PubMed ID: 24198417
[TBL] [Abstract][Full Text] [Related]
19. Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.
Ngo N; Henthorn KS; Cisneros MI; Cubitt B; Iwasaki M; de la Torre JC; Lama J
J Virol; 2015 Nov; 89(21):10924-33. PubMed ID: 26292327
[TBL] [Abstract][Full Text] [Related]
20. Severe hemorrhagic fever in strain 13/N guinea pigs infected with Lujo virus.
Bird BH; Dodd KA; Erickson BR; Albariño CG; Chakrabarti AK; McMullan LK; Bergeron E; Ströeher U; Cannon D; Martin B; Coleman-McCray JD; Nichol ST; Spiropoulou CF
PLoS Negl Trop Dis; 2012; 6(8):e1801. PubMed ID: 22953019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
